Signal Genetics Sues Med BioGene

Signal has alleged that Med BioGene breached the provisions in a term sheet inked between the two companies regarding an exclusive, worldwide license for Med BioGene's LungExpress Dx test.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.